Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William E Carson

Showing results (171-180 of 272) with videos related to

Pageof 28
Sort By:
Molecular Cancer Therapeutics|January 28, 2010
Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosisKristan D Guenterberg, Valerie P Grignol, Ene T Raig, et al.
Cancer Biology & Therapy|March 27, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATPJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
Psychoneuroendocrinology|June 5, 2021
Distress Trajectories in Black and White Breast Cancer Survivors: From Diagnosis to SurvivorshipAnnelise A Madison, Juan Peng, M Rosie Shrout, et al.
Clinical Lung Cancer|November 25, 2020
Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor CellsDwight H Owen, Brooke Benner, Carly Pilcher, et al.
Cancer Immunology, Immunotherapy : CII|September 2, 2016
A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomasMegan C Duggan, Caroline Jochems, Renee N Donahue, et al.
Nature Communications|December 15, 2021
Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapyWenqing Li, Xinfu Zhang, Chengxiang Zhang, et al.
Brain, Behavior, and Immunity|November 22, 2021
The gut connection: Intestinal permeability as a pathway from breast cancer survivors' relationship satisfaction to inflammation across treatmentM Rosie Shrout, Annelise A Madison, Megan E Renna, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 21, 2005
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901John D Roberts, Donna Niedzwiecki, William E Carson, et al.
The Journal of Investigative Dermatology|October 6, 2022
Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous MelanomaMallory J DiVincenzo, Emily Schwarz, Casey Ren, et al.
Psycho-Oncology|December 21, 2012
Beta-blockers may reduce intrusive thoughts in newly diagnosed cancer patientsMonica E Lindgren, Christopher P Fagundes, Catherine M Alfano, et al.
Pageof 28

Showing results (171-180 of 272) with videos related to

Sort By:
Pageof 28
Molecular Cancer Therapeutics|January 28, 2010
Interleukin-29 binds to melanoma cells inducing Jak-STAT signal transduction and apoptosisKristan D Guenterberg, Valerie P Grignol, Ene T Raig, et al.
Cancer Biology & Therapy|March 27, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATPJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
Psychoneuroendocrinology|June 5, 2021
Distress Trajectories in Black and White Breast Cancer Survivors: From Diagnosis to SurvivorshipAnnelise A Madison, Juan Peng, M Rosie Shrout, et al.
Clinical Lung Cancer|November 25, 2020
Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor CellsDwight H Owen, Brooke Benner, Carly Pilcher, et al.
Cancer Immunology, Immunotherapy : CII|September 2, 2016
A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomasMegan C Duggan, Caroline Jochems, Renee N Donahue, et al.
Nature Communications|December 15, 2021
Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapyWenqing Li, Xinfu Zhang, Chengxiang Zhang, et al.
Brain, Behavior, and Immunity|November 22, 2021
The gut connection: Intestinal permeability as a pathway from breast cancer survivors' relationship satisfaction to inflammation across treatmentM Rosie Shrout, Annelise A Madison, Megan E Renna, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 21, 2005
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901John D Roberts, Donna Niedzwiecki, William E Carson, et al.
The Journal of Investigative Dermatology|October 6, 2022
Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous MelanomaMallory J DiVincenzo, Emily Schwarz, Casey Ren, et al.
Psycho-Oncology|December 21, 2012
Beta-blockers may reduce intrusive thoughts in newly diagnosed cancer patientsMonica E Lindgren, Christopher P Fagundes, Catherine M Alfano, et al.
Pageof 28